Watch our interview with Matthew Henn, Executive Vice President and Chief Scientific Officer of Seres Therapeutics.
Home » Matthew Henn (Seres Therapeutics): ‘Microbiome research will have a large impact on human health’
MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome
Published by Clorofilla Srl
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED